Bile acids: Regulation of apoptosis by ursodeoxycholic acid

Journal of Lipid Research

Volumn 50, Issue 9, 2009, Pages 1721-1734

  Amaral, Joana D ^a   Viana, Ricardo J S ^a   Ramalho, Rita M ^a   Steer, Clifford J ^b   Rodrigues, Cecilia M P ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Bcl 2 family; Cell death; Liver; Neuroprotection; Nuclear steroid receptors

Indexed keywords

BILE ACID; CASPASE 8; DEATH RECEPTOR; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; TAUROCHENODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ALZHEIMER DISEASE; APOPTOSIS; BILE SECRETION; CELL CYCLE REGULATION; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL PROTECTION; CELL SURVIVAL; COLON CANCER; DEGENERATIVE DISEASE; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; HUMAN; INTRAHEPATIC CHOLESTASIS; LIPID ANALYSIS; LIPID METABOLISM; LIVER FUNCTION; LIVER PROTECTION; MEMBRANE STABILIZATION; MITOCHONDRIAL RESPIRATION; MOLECULAR MECHANICS; NONHUMAN; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BILE ACIDS AND SALTS; HUMANS; SIGNAL TRANSDUCTION; URSODEOXYCHOLIC ACID;

EID: 70350417325     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.R900011-JLR200     Document Type: Review

References (145)

1. Bayerdorffer, E., G. A. Mannes, W. O. Richter, T. Ochsenkuhn, B. Wiebecke, W. Kopcke, and G. Paumgartner. 1993. Increased serum deoxycholic acid levels in men with colorectal adenomas. Gastroenterology. 104: 145-151.
2. Patel, T., and G. J. Gores. 1995. Apoptosis and hepatobiliary disease. Hepatology. 21: 1725-1741.
3. Hofmann, A. F., and A. Roda. 1984. Physicochemical properties of bile acids and their relationship to biological properties: an overview of the problem. J. Lipid Res. 25: 1477-1489.
4. Babu, P., N. Sangeetha, and U. Maitra. 2006. Supramolecular chemistry of bile acids derivatives: formation of gels. Macromol. Symp. 241: 60-67.
5. Russell, D. W., and K. D. Setchell. 1992. Bile acid biosynthesis. Biochemistry. 31: 4737-4749.
6. Rodrigues, C. M., and C. J. Steer. 2000. The neuroprotective characteristic of ursodeoxycholic acid and its conjugates. In Biology of Bile Acids in Health and Disease. G. van Berge Henegouwen, D. Keppler, U. Leuschner, G. Paumgartner, and A. Stiehl, editors. Kluwer Academic Publishers, Dordrecht, The Netherlands. 255-270.
7. Chiang, J. Y. 2004. Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms. J. Hepatol. 40: 539-551.
8. Li, T., W. Chen, and J. Y. Chiang. 2007. PXR induces CYP27A1 and regulates cholesterol metabolism in the intestine. J. Lipid Res. 48: 373-384.
9. Han, S., and J. Y. Chiang. 2009. Mechanism of vitamin D receptor inhibition of cholesterol 7α-hydroxylase gene transcription in human hepatocytes. Drug Metab. Dispos. 37: 469-478.
10. Lew, J. L., A. Zhao, J. Yu, L. Huang, N. De Pedro, F. Pelaez, S. D. Wright, and J. Cui. 2004. The farnesoid X receptor controls gene expression in a ligand- and promoter-selective fashion. J. Biol. Chem. 279: 8856-8861.
11. Russell, D. W. 2003. The enzymes, regulation, and genetics of bile acid synthesis. Annu. Rev. Biochem. 72: 137-174.
12. Goodwin, B., S. A. Jones, R. R. Price, M. A. Watson, D. D. McKee, L. B. Moore, C. Galardi, J. G. Wilson, M. C. Lewis, M. E. Roth, et al. 2000. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. Mol. Cell. 6: 517-526.
13. Lu, T. T., M. Makishima, J. J. Repa, K. Schoonjans, T. A. Kerr, J. Auwerx, and D. J. Mangelsdorf. 2000. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Mol. Cell. 6: 507-515.
14. Mataki, C., B. C. Magnier, S. M. Houten, J. S. Annicotte, C. Argmann, C. Thomas, H. Overmars, W. Kulik, D. Metzger, J. Auwerx, et al. 2007. Compromised intestinal lipid absorption in mice with a liver-specific deficiency of liver receptor homolog 1. Mol. Cell. Biol. 27: 8330-8339.
15. Lee, Y. K., D. R. Schmidt, C. L. Cummins, M. Choi, L. Peng, Y. Zhang, B. Goodwin, R. E. Hammer, D. J. Mangelsdorf, and S. A. Kliewer. 2008. Liver receptor homolog-1 regulates bile acid homeostasis but is not essential for feedback regulation of bile acid synthesis. Mol. Endocrinol. 22: 1345-1356.
16. Kerr, T. A., S. Saeki, M. Schneider, K. Schaefer, S. Berdy, T. Redder, B. Shan, D. W. Russell, and M. Schwarz. 2002. Loss of nuclear receptor SHP impairs but does not eliminate negative feedback regulation of bile acid synthesis. Dev. Cell. 2: 713-720.
17. Wang, L., Y. K. Lee, D. Bundman, Y. Han, S. Thevananther, C. S. Kim, S. S. Chua, P. Wei, R. A. Heyman, M. Karin, et al. 2002. Redundant pathways for negative feedback regulation of bile acid production. Dev. Cell. 2: 721-731.
18. Inagaki, T., M. Choi, A. Moschetta, L. Peng, C. L. Cummins, J. G. McDonald, G. Luo, S. A. Jones, B. Goodwin, J. A. Richardson, et al. 2005. Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis. Cell Metab. 2: 217-225.
19. Holt, J. A., G. Luo, A. N. Billin, J. Bisi, Y. Y. McNeill, K. F. Kozarsky, M. Donahee, D. Y. Wang, T. A. Mansfield, S. A. Kliewer, et al. 2003. Definition of a novel growth factor-dependent signal cascade for the suppression of bile acid biosynthesis. Genes Dev. 17: 1581-1591.
20. Kim, I., S. H. Ahn, T. Inagaki, M. Choi, S. Ito, G. L. Guo, S. A. Kliewer, and F. J. Gonzalez. 2007. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J. Lipid Res. 48: 2664-2672.
21. Rao, A., J. Haywood, A. L. Craddock, M. G. Belinsky, G. D. Kruh, and P. A. Dawson. 2008. The organic solute transporter α-β, Ostα-Ostβ, is essential for intestinal bile acid transport and homeostasis. Proc. Natl. Acad. Sci. USA. 105: 3891-3896.
22. Maruyama, T., Y. Miyamoto, T. Nakamura, Y. Tamai, H. Okada, E. Sugiyama, T. Nakamura, H. Itadani, and K. Tanaka. 2002. Identification of membrane-type receptor for bile acids (M-BAR). Biochem. Biophys. Res. Commun. 298: 714-719.
23. Kawamata, Y., R. Fujii, M. Hosoya, M. Harada, H. Yoshida, M. Miwa, S. Fukusumi, Y. Habata, T. Itoh, Y. Shintani, et al. 2003. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278: 9435-9440.
24. Keitel, V., R. Kubitz, and D. Haussinger. 2008. Endocrine and paracrine role of bile acids. World J. Gastroenterol. 14: 5620-5629.
25. Geier, A., M. Wagner, C. G. Dietrich, and M. Trauner. 2007. Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. Biochim. Biophys. Acta. 1773: 283-308.
26. Ma, K., P. K. Saha, L. Chan, and D. D. Moore. 2006. Farnesoid X receptor is essential for normal glucose homeostasis. J. Clin. Invest. 116: 1102-1109.
27. Daniel, P. T. 2000. Dissecting the pathways to death. Leukemia. 14: 2035-2044.
28. Kerr, J. F., A. H. Wyllie, and A. R. Currie. 1972. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer. 26: 239-257.
29. Reed, J. C. 2002. Apoptosis-based therapies. Nat. Rev. Drug Discov. 1: 111-121.
30. Shi, Y. 2002. Mechanisms of caspase activation and inhibition during apoptosis. Mol. Cell. 9: 459-470.
31. Ashkenazi, A. 2002. Targeting death and decoy receptors of the tumour-necrosis factor superfamily. Nat. Rev. Cancer. 2: 420-430.
32. Kroemer, G., L. Galluzzi, and C. Brenner. 2007. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87: 99-163.
33. Youle, R. J., and A. Strasser. 2008. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 9: 47-59.
34. Krammer, P. H. 1999. CD95(APO-1/Fas)-mediated apoptosis: live and let die. Adv. Immunol. 71: 163-210.
35. Locksley, R. M., N. Killeen, and M. J. Lenardo. 2001. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 104: 487-501.
36. Mehlen, P., and D. E. Bredesen. 2004. The dependence receptor hypothesis. Apoptosis. 9: 37-49.
37. Peter, M. E., and P. H. Krammer. 2003. The CD95(APO-1/Fas) DISC and beyond. Cell Death Differ. 10: 26-35.
38. Li, S., Y. Zhao, X. He, T. H. Kim, D. K. Kuharsky, H. Rabinowich, J. Chen, C. Du, and X. M. Yin. 2002. Relief of extrinsic pathway inhibition by the Bid-dependent mitochondrial release of Smac in Fas-mediated hepatocyte apoptosis. J. Biol. Chem. 277: 26912-26920.
39. Eskes, R., S. Desagher, B. Antonsson, and J. C. Martinou. 2000. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 20: 929-935.
40. Reed, S. I. 1997. Control of the G1/S transition. Cancer Surv. 29: 7-23.
41. Wang, C., Z. Li, M. Fu, T. Bouras, and R. G. Pestell. 2004. Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential. Cancer Treat. Res. 119: 217-237.
42. Han, E. K., S. C. Ng, N. Arber, M. Begemann, and I. B. Weinstein. 1999. Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis. Apoptosis. 4: 213-219.
43. Freeman, R. S., S. Estus, and E. M. Johnson, Jr. 1994. Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of cyclin D1 during programmed cell death. Neuron. 12: 343-355.
44. Nevins, J. R. 1998. Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9: 585-593.
45. Sofer-Levi, Y., and D. Resnitzky. 1996. Apoptosis induced by ectopic expression of cyclin D1 but not cyclin E. Oncogene. 13: 2431-2437.
46. Michael, D., and M. Oren. 2003. The p53-Mdm2 module and the ubiquitin system. Semin. Cancer Biol. 13: 49-58.
47. Jacotot, E., K. F. Ferri, and G. Kroemer. 2000. Apoptosis and cell cycle: distinct checkpoints with overlapping upstream control. Pathol. Biol. 48: 271-279.
48. Barone, M., A. Francavilla, L. Polimeno, E. Ierardi, D. Romanelli, P. Berloco, A. Di Leo, and C. Panella. 1996. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies. Hepatology. 23: 1159-1166.
49. Maher, J. J. 2004. What doesn't kill you makes you stronger: how hepatocytes survive prolonged cholestasis. Hepatology. 39: 1141-1143.
50. Faubion, W. A., M. E. Guicciardi, H. Miyoshi, S. F. Bronk, P. J. Roberts, P. A. Svingen, S. H. Kaufmann, and G. J. Gores. 1999. Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J. Clin. Invest. 103: 137-145.
51. Rodrigues, C. M., G. Fan, P. Y. Wong, B. T. Kren, and C. J. Steer. 1998. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol. Med. 4: 165-178.
52. Yerushalmi, B., R. Dahl, M. W. Devereaux, E. Gumpricht, and R. J. Sokol. 2001. Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition. Hepatology. 33: 616-626.
53. Higuchi, H., J. H. Yoon, A. Grambihler, N. Werneburg, S. F. Bronk, and G. J. Gores. 2003. Bile acids stimulate cFLIP phosphorylation enhancing TRAIL-mediated apoptosis. J. Biol. Chem. 278: 454-461.
54. Sodeman, T., S. F. Bronk, P. J. Roberts, H. Miyoshi, and G. J. Gores. 2000. Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G992-G999.
55. Katona, B. W., S. Anant, D. F. Covey, and W. F. Stenson. 2009. Characterization of enantiomeric bile acid-induced apoptosis in colon cancer cell lines. J. Biol. Chem. 284: 3354-3364.
56. Qiao, L., E. Studer, K. Leach, R. McKinstry, S. Gupta, R. Decker, R. Kukreja, K. Valerie, P. Nagarkatti, W. El Deiry, et al. 2001. Deoxycholic acid (DCA) causes ligand-independent activation of epidermal growth factor receptor (EGFR) and FAS receptor in primary hepatocytes: inhibition of EGFR/mitogen-activated protein kinase-signaling module enhances DCA-induced apoptosis. Mol. Biol. Cell. 12: 2629-2645.
57. Sokol, R. J., M. Devereaux, R. Dahl, and E. Gumpricht. 2006. "Let there be bile"-understanding hepatic injury in cholestasis. J. Pediatr. Gastroenterol. Nutr. 43 (Suppl. 1): S4-S9.
58. Reinehr, R., S. Becker, A. Eberle, S. Grether-Beck, and D. Haussinger. 2005. Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J. Biol. Chem. 280: 27179-27194.
59. Yang, J. I., J. H. Yoon, S. J. Myung, G. Y. Gwak, W. Kim, G. E. Chung, S. H. Lee, S. M. Lee, C. Y. Kim, and H. S. Lee. 2007. Bile acid-induced TGR5-dependent c-Jun-N terminal kinase activation leads to enhanced caspase 8 activation in hepatocytes. Biochem. Biophys. Res. Commun. 361: 156-161.
60. Katona, B. W., C. L. Cummins, A. D. Ferguson, T. Li, D. R. Schmidt, D. J. Mangelsdorf, and D. F. Covey. 2007. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. J. Med. Chem. 50: 6048-6058.
61. Bennett, M., K. Macdonald, S. W. Chan, J. P. Luzio, R. Simari, and P. Weissberg. 1998. Cell surface trafficking of Fas: a rapid mechanism of p53-mediated apoptosis. Science. 282: 290-293.
62. Zhang, G., M. A. Park, C. Mitchell, T. Walker, H. Hamed, E. Studer, M. Graf, M. Rahmani, S. Gupta, P. B. Hylemon, et al. 2008. Multiple cyclin kinase inhibitors promote bile acid-induced apoptosis and autophagy in primary hepatocytes via p53-CD95-dependent signaling. J. Biol. Chem. 283: 24343-24358.
63. Rust, C., N. Wild, C. Bernt, T. Vennegeerts, R. Wimmer, and U. Beuers. 2009. Bile acid-induced apoptosis in hepatocytes is caspase-6-dependent. J. Biol. Chem. 284: 2908-2916.
64. Tsuchiya, S., M. Tsuji, Y. Morio, and K. Oguchi. 2006. Involvement of endoplasmic reticulum in glycochenodeoxycholic acid-induced apoptosis in rat hepatocytes. Toxicol. Lett. 166: 140-149.
65. Iizaka, T., M. Tsuji, H. Oyamada, Y. Morio, and K. Oguchi. 2007. Interaction between caspase-8 activation and endoplasmic reticulum stress in glycochenodeoxycholic acid-induced apoptotic HepG2 cells. Toxicology. 241: 146-156.
66. Schoemaker, M. H., L. Conde de la Rosa, M. Buist-Homan, T. E. Vrenken, R. Havinga, K. Poelstra, H. J. Haisma, P. L. Jansen, and H. Moshage. 2004. Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology. 39: 1563-1573.
67. Schoemaker, M. H., W. M. Gommans, L. C. de la Rosa, M. Homan, P. Klok, C. Trautwein, H. van Goor, K. Poelstra, H. J. Haisma, P. L. Jansen, et al. 2003. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-κB activation. J. Hepatol. 39: 153-161.
68. Oh, S. H., J. X. Nan, D. W. Sohn, Y. C. Kim, and B. H. Lee. 2002. Salvia miltiorrhiza inhibits biliary obstruction-induced hepatocyte apoptosis by cytoplasmic sequestration of p53. Toxicol. Appl. Pharmacol. 182: 27-33.
69. Rao, Y. P., E. J. Studer, R. T. Stravitz, S. Gupta, L. Qiao, P. Dent, and P. B. Hylemon. 2002. Activation of the Raf-1/MEK/ERK cascade by bile acids occurs via the epidermal growth factor receptor in primary rat hepatocytes. Hepatology. 35: 307-314.
70. Qiao, L., S. I. Han, Y. Fang, J. S. Park, S. Gupta, D. Gilfor, G. Amorino, K. Valerie, L. Sealy, J. F. Engelhardt, et al. 2003. Bile acid regulation of C/EBPβ, CREB, and c-Jun function, via the extracellular signal-regulated kinase and c-Jun NH2-terminal kinase pathways, modulates the apoptotic response of hepatocytes. Mol. Cell. Biol. 23: 3052-3066.
71. Liedtke, C., J. Plumpe, S. Kubicka, C. A. Bradham, M. P. Manns, D. A. Brenner, and C. Trautwein. 2002. Jun kinase modulates tumor necrosis factor-dependent apoptosis in liver cells. Hepatology. 36: 315-325.
72. Gupta, S., R. Natarajan, S. G. Payne, E. J. Studer, S. Spiegel, P. Dent, and P. B. Hylemon. 2004. Deoxycholic acid activates the c-Jun N-terminal kinase pathway via FAS receptor activation in primary hepatocytes. Role of acidic sphingomyelinase-mediated ceramide generation in FAS receptor activation. J. Biol. Chem. 279: 5821-5828.
73. Rust, C., L. M. Karnitz, C. V. Paya, J. Moscat, R. D. Simari, and G. J. Gores. 2000. The bile acid taurochenodeoxycholate activates a phosphatidylinositol 3-kinase-dependent survival signaling cascade. J. Biol. Chem. 275: 20210-20216.
74. Torchia, E. C., A. Stolz, and L. B. Agellon. 2001. Differential modulation of cellular death and survival pathways by conjugated bile acids. BMC Biochem. 2: 11.
75. Qiao, L., A. Yacoub, E. Studer, S. Gupta, X. Y. Pei, S. Grant, P. B. Hylemon, and P. Dent. 2002. Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes. Hepatology. 35: 779-789.
76. Im, E., and J. D. Martinez. 2004. Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/ Raf-1/ERK signaling in human colon cancer cells. J. Nutr. 134: 483-486.
77. Guicciardi, M. E., and G. J. Gores. 2002. Ursodeoxycholic acid cytoprotection: dancing with death receptors and survival pathways. Hepatology. 35: 971-973.
78. Beuers, U., J. L. Boyer, and G. Paumgartner. 1998. Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology. 28: 1449-1453.
79. Lazaridis, K. N., G. J. Gores, and K. D. Lindor. 2001. Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. J. Hepatol. 35: 134-146.
80. Paumgartner, G., and U. Beuers. 2002. Ursodeoxycholic acid in cholestatic liver disease: mechanisms of action and therapeutic use revisited. Hepatology. 36: 525-531.
81. Benz, C., S. Angermuller, U. Tox, P. Kloters-Plachky, H. D. Riedel, P. Sauer, W. Stremmel, and A. Stiehl. 1998. Effect of tauroursodeoxycholic acid on bile-acid-induced apoptosis and cytolysis in rat hepatocytes. J. Hepatol. 28: 99-106.
82. Rodrigues, C. M., G. Fan, X. Ma, B. T. Kren, and C. J. Steer. 1998. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101: 2790-2799.
83. Benz, C., S. Angermuller, G. Otto, P. Sauer, W. Stremmel, and A. Stiehl. 2000. Effect of tauroursodeoxycholic acid on bile acid-induced apoptosis in primary human hepatocytes. Eur. J. Clin. Invest. 30: 203-209.
84. Castro, R., S. Solá, C. Steer, and C. Rodrigues. 2007. Bile acids as modulators of apoptosis. In Hepatotoxicity: From Genomics to in-Vitro and in-Vivo Models. S. Sahu, editor. John Wiley & Sons, West Sussex, UK. 391-419.
85. Rodrigues, C. M., X. Ma, C. Linehan-Stieers, G. Fan, B. T. Kren, and C. J. Steer. 1999. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6: 842-854.
86. Rodrigues, C. M., S. Sola, J. C. Sharpe, J. J. Moura, and C. J. Steer. 2003. Tauroursodeoxycholic acid prevents Bax-induced membrane perturbation and cytochrome C release in isolated mitochondria. Biochemistry. 42: 3070-3080.
87. Azzaroli, F., W. Mehal, C. J. Soroka, L. Wang, J. Lee, N. Crispe, and J. L. Boyer. 2002. Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology. 36: 49-54.
88. Xie, Q., V. I. Khaoustov, C. C. Chung, J. Sohn, B. Krishnan, D. E. Lewis, and B. Yoffe. 2002. Effect of tauroursodeoxycholic acid on endoplasmic reticulum stress-induced caspase-12 activation. Hepatology. 36: 592-601.
89. Ozcan, U., E. Yilmaz, L. Ozcan, M. Furuhashi, E. Vaillancourt, R. O. Smith, C. Z. Gorgun, and G. S. Hotamisligil. 2006. Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science. 313: 1137-1140.
90. Setchell, K. D., C. M. Rodrigues, C. Clerici, A. Solinas, A. Morelli, C. Gartung, and J. Boyer. 1997. Bile acid concentrations in human and rat liver tissue and in hepatocyte nuclei. Gastroenterology. 112: 226-235.
91. Monte, M. J., M. C. Martinez-Diez, M. Y. El-Mir, M. E. Mendoza, P. Bravo, O. Bachs, and J. J. Marin. 2002. Changes in the pool of bile acids in hepatocyte nuclei during rat liver regeneration. J. Hepatol. 36: 534-542.
92. Solá, S., J. D. Amaral, R. E. Castro, R. M. Ramalho, P. M. Borralho, B. T. Kren, H. Tanaka, C. J. Steer, and C. M. Rodrigues. 2005. Nuclear translocation of UDCA by the glucocorticoid receptor is required to reduce TGF-β 1-induced apoptosis in rat hepatocytes. Hepatology. 42: 925-934.
93. Castro, R. E., S. Solá, X. Ma, R. M. Ramalho, B. T. Kren, C. J. Steer, and C. M. Rodrigues. 2005. A distinct microarray gene expression profile in primary rat hepatocytes incubated with ursodeoxycholic acid. J. Hepatol. 42: 897-906.
94. Castro, R. E., J. D. Amaral, S. Sola, B. T. Kren, C. J. Steer, and C. M. Rodrigues. 2007. Differential regulation of cyclin D1 and cell death by bile acids in primary rat hepatocytes. Am. J. Physiol. Gastrointest Liver Physiol. 293: G327-G334.
95. Pusl, T., T. Vennegeerts, R. Wimmer, G. U. Denk, U. Beuers, and C. Rust. 2008. Tauroursodeoxycholic acid reduces bile acid-induced apoptosis by modulation of AP-1. Biochem. Biophys. Res. Commun. 367: 208-212.
96. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136.
97. Solá, S., X. Ma, R. E. Castro, B. T. Kren, C. J. Steer, and C. M. Rodrigues. 2003. Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor β1-induced apoptosis of rat hepatocytes. J. Biol. Chem. 278: 48831-48838.
98. Amaral, J. D., R. E. Castro, S. Sola, C. J. Steer, and C. M. Rodrigues. 2007. p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J. Biol. Chem. 282: 34250-34259.
99. Serfaty, L., A. De Leusse, O. Rosmorduc, B. Desaint, J. F. Flejou, O. Chazouilleres, R. E. Poupon, and R. Poupon. 2003. Ursodeoxycholic acid therapy and the risk of colorectal adenoma in patients with primary biliary cirrhosis: an observational study. Hepatology. 38: 203-209.
100. Tung, B. Y., M. J. Emond, R. C. Haggitt, M. P. Bronner, M. B. Kimmey, K. V. Kowdley, and T. A. Brentnall. 2001. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann. Intern. Med. 134: 89-95.
101. Earnest, D. L., H. Holubec, R. K. Wali, C. S. Jolley, M. Bissonette, A. K. Bhattacharyya, H. Roy, S. Khare, and T. A. Brasitus. 1994. Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res. 54: 5071-5074.
102. Wali, R. K., S. Khare, M. Tretiakova, G. Cohen, L. Nguyen, J. Hart, J. Wang, M. Wen, A. Ramaswamy, L. Joseph, et al. 2002. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol. Biomarkers Prev. 11: 1653-1662.
103. Wali, R. K., D. Stoiber, L. Nguyen, J. Hart, M. D. Sitrin, T. Brasitus, and M. Bissonnette. 2002. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development. Cancer Epidemiol. Biomarkers Prev. 11: 1316-1321.
104. Park, H., M. K. Kim, and S. U. Kim. 2008. Ursodeoxycholic acid prevents apoptosis of mouse sensory neurons induced by cisplatin by reducing P53 accumulation. Biochem Biophys Res Commun. 377: 1025-1030.
105. Solá, S., R. E. Castro, P. A. Laires, C. J. Steer, and C. M. Rodrigues. 2003. Tauroursodeoxycholic acid prevents amyloid-β peptide-induced neuronal death via a phosphatidylinositol 3-kinase-dependent signaling pathway. Mol. Med. 9: 226-234.
106. Rajesh, K. G., R. Suzuki, H. Maeda, M. Yamamoto, X. Yutong, and S. Sasaguri. 2005. Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway. J. Mol. Cell. Cardiol. 39: 766-776.
107. Miura, T., R. Ouchida, N. Yoshikawa, K. Okamoto, Y. Makino, T. Nakamura, C. Morimoto, I. Makino, and H. Tanaka. 2001. Functional modulation of the glucocorticoid receptor and suppression of NF-κB-dependent transcription by ursodeoxycholic acid. J. Biol. Chem. 276: 47371-47378.
108. Sionov, R. V., O. Cohen, S. Kfir, Y. Zilberman, and E. Yefenof. 2006. Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis. J. Exp. Med. 203: 189-201.
109. Rasmuson, S., R. Andrew, B. Nasman, J. R. Seckl, B. R. Walker, and T. Olsson. 2001. Increased glucocorticoid production and altered cortisol metabolism in women with mild to moderate Alzheimer's disease. Biol. Psychiatry. 49: 547-552.
110. Kim, S., B. S. Jeon, C. Heo, P. S. Im, T. B. Ahn, J. H. Seo, H. S. Kim, C. H. Park, S. H. Choi, S. H. Cho, et al. 2004. A-synuclein induces apoptosis by altered expression in human peripheral lymphocyte in Parkinson's disease. FASEB J. 18: 1615-1617.
111. Yamamoto, M., K. Fukuda, N. Miura, R. Suzuki, T. Kido, and Y. Komatsu. 1998. Inhibition by dexamethasone of transforming growth factor β 1-induced apoptosis in rat hepatoma cells: a possible association with Bcl-xL induction. Hepatology. 27: 959-966.
112. Bailly-Maitre, B., G. de Sousa, K. Boulukos, J. Gugenheim, and R. Rahmani. 2001. Dexamethasone inhibits spontaneous apoptosis in primary cultures of human and rat hepatocytes via Bcl-2 and Bcl-xL induction. Cell Death Differ. 8: 279-288.
113. Karabelyos, C., O. Dobozy, C. Szalai, K. Klenjanszki, K. Varju, A. Hadhazi, A. Kiss, A. K. Fulop, B. Madarasz, and A. Falus. 1999. Elevated hepatic glucocorticoid receptor expression during liver regeneration in rats. Pathol. Oncol. Res. 5: 107-109.
114. Sengupta, S., and B. Wasylyk. 2004. Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors. Ann. N. Y. Acad. Sci. 1024: 54-71.
115. Solá, S., R. E. Castro, B. T. Kren, C. J. Steer, and C. M. Rodrigues. 2004. Modulation of nuclear steroid receptors by ursodeoxycholic acid inhibits TGF-β1-induced E2F-1/p53-mediated apoptosis of rat hepatocytes. Biochemistry. 43: 8429-8438.
116. Rogatsky, I., J. M. Trowbridge, and M. J. Garabedian. 1997. Glucocorticoid receptor-mediated cell cycle arrest is achieved through distinct cell-specific transcriptional regulatory mechanisms. Mol. Cell. Biol. 17: 3181-3193.
117. Tanaka, H., Y. Makino, T. Miura, F. Hirano, K. Okamoto, K. Komura, Y. Sato, and I. Makino. 1996. Ligand-independent activation of the glucocorticoid receptor by ursodeoxycholic acid. Repression of IFN-gamma-induced MHC class II gene expression via a glucocorticoid receptor-dependent pathway. J. Immunol. 156: 1601-1608.
118. Mitsuyoshi, H., T. Nakashima, K. Inaba, H. Ishikawa, Y. Nakajima, Y. Sakamoto, M. Matsumoto, T. Okanoue, and K. Kashima. 1997. Ursodeoxycholic acid enhances glucocorticoid-induced tyrosine aminotransferase-gene expression in cultured rat hepatocytes. Biochem. Biophys. Res. Commun. 240: 732-736.
119. Planey, S. L., A. Derfoul, A. Steplewski, N. M. Robertson, and G. Litwack. 2002. Inhibition of glucocorticoid-induced apoptosis in 697 pre-B lymphocytes by the mineralocorticoid receptor N-terminal domain. J. Biol. Chem. 277: 42188-42196.
120. Almeida, O. F., G. L. Conde, C. Crochemore, B. A. Demeneix, D. Fischer, A. H. Hassan, M. Meyer, F. Holsboer, and T. M. Michaelidis. 2000. Subtle shifts in the ratio between pro- and antiapoptotic molecules after activation of corticosteroid receptors decide neuronal fate. FASEB J. 14: 779-790.
121. Solá, S., J. D. Amaral, P. M. Borralho, R. M. Ramalho, R. E. Castro, M. M. Aranha, C. J. Steer, and C. M. Rodrigues. 2006. Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid β-peptide-induced apoptosis. Mol. Endocrinol. 20: 2292-2303.
122. Howard, W. R., J. A. Pospisil, E. Njolito, and D. J. Noonan. 2000. Catabolites of cholesterol synthesis pathways and forskolin as activators of the farnesoid X-activated nuclear receptor. Toxicol. Appl. Pharmacol. 163: 195-202.
123. Chiang, J. Y., R. Kimmel, C. Weinberger, and D. Stroup. 2000. Farnesoid X receptor responds to bile acids and represses cholesterol 7α-hydroxylase gene (CYP7A1) transcription. J. Biol. Chem. 275: 10918-10924.
124. Stedman, C., G. Robertson, S. Coulter, and C. Liddle. 2004. Feed-forward regulation of bile acid detoxification by CYP3A4: studies in humanized transgenic mice. J. Biol. Chem. 279: 11336-11343.
125. Przedborski, S., M. Vila, and V. Jackson-Lewis. 2003. Neurodegeneration: what is it and where are we? J. Clin. Invest. 111: 3-10.
126. Bredesen, D. E., R. V. Rao, and P. Mehlen. 2006. Cell death in the nervous system. Nature. 443: 796-802.
127. Keene, C. D., C. M. Rodrigues, T. Eich, C. Linehan-Stieers, A. Abt, B. T. Kren, C. J. Steer, and W. C. Low. 2001. A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease. Exp. Neurol. 171: 351-360.
128. Rodrigues, C. M., C. L. Stieers, C. D. Keene, X. Ma, B. T. Kren, W. C. Low, and C. J. Steer. 2000. Tauroursodeoxycholic acid partially prevents apoptosis induced by 3-nitropropionic acid: evidence for a mitochondrial pathway independent of the permeability transition. J. Neurochem. 75: 2368-2379.
129. Keene, C. D., C. M. Rodrigues, T. Eich, M. S. Chhabra, C. J. Steer, and W. C. Low. 2002. Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease. Proc. Natl. Acad. Sci. USA. 99: 10671-10676.
130. Duan, W. M., C. M. Rodrigues, L. R. Zhao, C. J. Steer, and W. C. Low. 2002. Tauroursodeoxycholic acid improves the survival and function of nigral transplants in a rat model of Parkinson's disease. Cell Transplant. 11: 195-205.
131. Ved, R., S. Saha, B. Westlund, C. Perier, L. G. Burnam, A. Sluder, M. Hoener, C. M. Rodrigues, A. Alfonso, C. Steer, et al. 2005. Similar patterns of mitochondrial vulnerability and rescue induced by genetic modification of α-synuclein, parkin and DJ-1 in C. elegans. J. Biol. Chem. 280: 42655-42668.
132. Rodrigues, C. M., S. R. Spellman, S. Sola, A. W. Grande, C. Linehan-Stieers, W. C. Low, and C. J. Steer. 2002. Neuroprotection by a bile acid in an acute stroke model in the rat. J. Cereb. Blood Flow Metab. 22: 463-471.
133. Rodrigues, C. M., S. Sola, Z. Nan, R. E. Castro, P. S. Ribeiro, W. C. Low, and C. J. Steer. 2003. Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc. Natl. Acad. Sci. USA. 100: 6087-6092.
134. Phillips, M. J., T. A. Walker, H. Y. Choi, A. E. Faulkner, M. K. Kim, S. S. Sidney, A. P. Boyd, J. M. Nickerson, J. H. Boatright, and M. T. Pardue. 2008. Tauroursodeoxycholic acid preservation of photoreceptor structure and function in the rd10 mouse through postnatal day 30. Invest. Ophthalmol. Vis. Sci. 49: 2148-2155.
135. Colak, A., B. Kelten, A. Sagmanligil, O. Akdemir, A. Karaoglan, E. Sahan, O. Celik, and S. Barut. 2008. Tauroursodeoxycholic acid and secondary damage after spinal cord injury in rats. J. Clin. Neurosci. 15: 665-671.
136. Castro, R. E., S. Sola, R. M. Ramalho, C. J. Steer, and C. M. Rodrigues. 2004. The bile acid tauroursodeoxycholic acid modulates phosphorylation and translocation of bad via phosphatidylinositol 3-kinase in glutamate-induced apoptosis of rat cortical neurons. J. Pharmacol. Exp. Ther. 311: 845-852.
137. LaFerla, F. M., K. N. Green, and S. Oddo. 2007. Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neurosci. 8: 499-509.
138. Rodrigues, C. M., S. Sola, R. Silva, and D. Brites. 2000. Bilirubin and amyloid-β peptide induce cytochrome c release through mitochondrial membrane permeabilization. Mol. Med. 6: 936-946.
139. Ramalho, R. M., P. S. Ribeiro, S. Solá, R. E. Castro, C. J. Steer, and C. M. Rodrigues. 2004. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid β-peptide-induced apoptosis of PC12 cells. J. Neurochem. 90: 567-575.
140. Ramalho, R. M., P. M. Borralho, R. E. Castro, S. Solá, C. J. Steer, and C. M. Rodrigues. 2006. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells. J. Neurochem. 98: 1610-1618.
141. Ramalho, R. M., R. J. Viana, R. E. Castro, C. J. Steer, W. C. Low, and C. M. Rodrigues. 2008. Apoptosis in transgenic mice expressing the P301L mutated form of human tau. Mol. Med. 14: 309-317.
142. Rodrigues, C. M., S. Solá, M. A. Brito, C. D. Brondino, D. Brites, and J. J. Moura. 2001. Amyloid β-peptide disrupts mitochondrial membrane lipid and protein structure: protective role of tauroursodeoxycholate. Biochem. Biophys. Res. Commun. 281: 468-474.
143. Viana, R. J., A. F. Nunes, R. E. Castro, R. M. Ramalho, J. Meyerson, S. Fossati, J. Ghiso, A. Rostagno, and C. M. Rodrigues. 2009. Tauroursodeoxycholic acid prevents E22Q Alzheimer's Aβ toxicity in human cerebral endothelial cells. Cell. Mol. Life Sci. 66: 1094-1104.
144. Gamblin, T. C., F. Chen, A. Zambrano, A. Abraha, S. Lagalwar, A. L. Guillozet, M. Lu, Y. Fu, F. Garcia-Sierra, N. LaPointe, et al. 2003. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc. Natl. Acad. Sci. USA. 100: 10032-10037.
145. Macedo, B., A. R. Batista, N. Ferreira, M. R. Almeida, and M. J. Saraiva. 2008. Anti-apoptotic treatment reduces transthyretin deposition in a transgenic mouse model of familial amyloidotic polyneuropathy. Biochim. Biophys. Acta. 1782: 517-522.